Gastrointestinal diffuse large B-cell lymphoma: Clinical characteristics and prognostic analysis from SEER database

Authors

  • Fang Du Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0009-0003-6141-9075
  • Lingyun Zhou Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China
  • Runya Fang Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China https://orcid.org/0009-0005-0821-6847
  • Jiao Chen Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0000-0001-5249-5437
  • Danbo Liu Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China
  • Hongxian Xiang Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0009-0002-0739-6813
  • Wenyi Lu Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0000-0001-9317-0655
  • Jingsong Wu Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0009-0009-0455-8240
  • Haifei Chen Department of Hematology, Luohu People's Hospital of Shenzhen, Shenzhen, China https://orcid.org/0009-0001-6367-1536

DOI:

https://doi.org/10.17305/bb.2025.12697

Keywords:

Gastrointestinal diffuse large B-cell lymphoma, SEER database, Prognostic factors, Nomogram, Survival analysis

Abstract

This study systematically analyzed the clinicopathological characteristics and prognostic factors of gastrointestinal diffuse large B-cell lymphoma (GI-DLBCL) patients using the SEER database. The Kaplan-Meier method was used to survival analysis, while LASSO regression analysis was utilized to further filter variables. The Pi for interaction was applied to verify the interactions in the multivariate analysis, and total survival risks were distinguished using hierarchical survival curves. Multivariate Cox regression analysis revealed that hazard ratio (HR) values indicated that age over 60 years (HR = 2.85), Ann Arbor stage (stage II: HR = 1.22; stage III: HR = 1.31; stage IV: HR = 1.85), and being widowed (HR = 1.40) were independent poor prognostic factors. In contrast, chemotherapy (HR = 0.37), radiotherapy (HR = 0.84), surgery (HR = 0.86), and lymph node resection (HR = 0.79) were associated with significant survival benefits. Additionally, an intestinal primary site (HR = 0.89), white race (HR = 0.78), and other races (HR = 0.65) were correlated with better prognosis. The nomogram model constructed from these independent prognostic factors demonstrated excellent predictive performance in both the training and validation cohorts, achieving a C-index of 0.71, significantly outperforming the traditional Ann Arbor staging system, which had a C-index of 0.56. Receiver operating characteristic (ROC) curve analysis indicated high discriminative ability for predicting 3-year, 5-year, and 10-year survival rates, with area under curve (AUC) values of 0.746, 0.756, and 0.756, respectively. Decision curve analysis (DCA) further confirmed the model's significant clinical net benefit across a wide range of threshold probabilities. The nomogram model developed in this study, based on extensive SEER database data, effectively predicts the prognosis of GI-DLBCL patients and provides a quantitative tool for individualized treatment.

Citations

Downloads

Download data is not yet available.
Gastrointestinal diffuse large B-cell lymphoma: Clinical characteristics and prognostic analysis from SEER database

Additional Files

Published

08-07-2025

How to Cite

1.
Gastrointestinal diffuse large B-cell lymphoma: Clinical characteristics and prognostic analysis from SEER database. Biomol Biomed [Internet]. 2025 Jul. 8 [cited 2025 Jul. 10];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12697